Evaluation of SARS-CoV2 antibody Rapid Diagnostic Test kits (RDTs) and Real Time-Polymerase Chain Reaction (Rt-PCR) for COVID-19 Diagnosis in Kaduna, Nigeria

Author:

Ige Oluwafemi,Buru Ayuba SundayORCID,Lamido Tanko Zainab,Mohammed Tahir,Dogara Livingstone,Patience Ijei Ifeoma,Halima Bello-Manga,Reward Audu,Samuel Ige,Grace Nmadu

Abstract

AbstractThe emergence of the RNA virus SARS-CoV2, the causative agent of COVID-19 and its declaration by the World Health Organization (WHO) as a pandemic has disrupted the delicate balance in health indices globally. Its attendant immune dysregulation and pathobiology is still evolving. Currently, real time PCR is the gold standard diagnostic test, however there are several invalidated antibody-based tests available for possible community screening. With ongoing community transmission in Nigeria, neither the true burden of COVID-19 nor the performance of these kits is presently known. This study therefore, compared the performance of the SARS CoV2 antibody test and the real time Polymerase Chain Reaction (Rt-PCR) in the diagnosis of COVID-19. For the purpose of this evaluation, we used the diagnostic test kit by Innovita® Biological Technology CO., LTD China, a total of 521 venous blood samples were collected from consenting patients for the SARS COVID-19 rapid diagnostic kit and Oral and Nasopharyngeal swabs were collected and analyzed using the real time Polymerase chain reaction technique for nucleic acid detection and quantification.

Publisher

Cold Spring Harbor Laboratory

Reference18 articles.

1. Nicola, M. , Alsafi, Z. , Sohrabi, C. , Kerwan, A. , Al-Jabir, A. , Iosifidis, C. , Agha, M. , & Agha, R. (2020). The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review. International journal of surgery (London, England), S1743-9191(20)30316-2. Advance online publication. https://doi.org/10.1016/j.ijsu.2020.04.018

2. Kaushik, S. , Kaushik, S. , Sharma, Y. et al. The Indian perspective of COVID-19 outbreak. VirusDis. (2020). https://doi.org/10.1007/s13337-020-00587-x

3. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis;China Medical Treatment Expert Group for COVID-19;The European respiratory journal,2020

4. Nigerian Center for Diseases Control, 2020. COVID-19 Cases Update, 16th October, 2020 Darrell Etherington. Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine. https://techcrunch.com/2020/03/17/pfizer-and-biontech-announce-joint-development-of-a-potential-covid-19-vaccine/. March 17, 2020

5. Jackson Ryan . Coronavirus vaccines: Drug trials, chloroquine and treatments for COVID-19.https://www.cnet.com/how-to/coronavirus-vaccines-drug-trials-chloroquine-and-treatments-for-covid-19/. April 1, 2020.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3